Cytogam: payments to doctors
Payments that named Cytogam as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 136
- Transactions
- 306
- Average per transaction
- $6,215
The per-transaction average — $6,215 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 136 providers the average total is $13,983, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| CSL Behring | $1,714,833 | 90.2% |
| Kamada LTD. | $120,383 | 6.3% |
| Saol Therapeutics Inc. | $27,273 | 1.4% |
| Kamada Ltd. | $23,200 | 1.2% |
| Saol International Limited | $16,000 | 0.8% |